| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2007 | CN1915259A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915258A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915257A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915256A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915255A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915254A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915251A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915250A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915249A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915246A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915245A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915242A Exterior coating medication for treating ulcer in the oral cavity, and preparation method |
| 02/21/2007 | CN1915240A Medication for treating ulcer of upper digestive tract |
| 02/21/2007 | CN1915239A Medication for treating gastric ulcer, duodenal ulcer |
| 02/21/2007 | CN1915238A Medicinal composition for improving effect of anti hepatic fibrosis |
| 02/21/2007 | CN1915237A Medicinal composition, preparation method and quality control method |
| 02/21/2007 | CN1915236A Application of woodruff glycoside in preparing medication for treating rheumatoid arthritis |
| 02/21/2007 | CN1915235A Application of woodruff acid with acetyl being removed in preparing medicine for treating rheumatoid arthritis |
| 02/21/2007 | CN1915234A New medicinal composition |
| 02/21/2007 | CN1915233A Medicine composition for treating anxiety neurosis, and oral cavity disintegration preparation |
| 02/21/2007 | CN1915232A Combination of baicalin and medication of chemical treatment in platinum family |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/21/2007 | CN1915230A Injection in large capacity of sodium sulfonate containing tanshinone óÄA and preparation method |
| 02/21/2007 | CN1915229A Medicine for treating chickens and pigs infected by mixed mycoplasma and other bacteria |
| 02/21/2007 | CN1915228A Soft capsule of indapamide |
| 02/21/2007 | CN1915226A Oral disintegration tablet of Loratadine ambroxol, and prepartion method |
| 02/21/2007 | CN1915225A Drop pills of Amlodipine, and preparation method |
| 02/21/2007 | CN1915224A Slowly released tablet of compound atenolol, and preparation method |
| 02/21/2007 | CN1915223A Chewing tablet of compound aluminum magnesium hydroxide, preparation method and method for measuring quality |
| 02/21/2007 | CN1915222A Composition of liposome, and preparation method |
| 02/21/2007 | CN1915221A Liposome of alkaloid in vinca, and preparation method |
| 02/21/2007 | CN1915220A Mitoxantrone or liposome of mitoxantrone hydrochloric acid, and preparation method |
| 02/21/2007 | CN1915218A Sodium sulfonate injection of tanshinone óÄA, and preparation method |
| 02/21/2007 | CN1915217A Self-emulsifying agent of compound artemether |
| 02/21/2007 | CN1915216A New usage of tandospirone and its derivative, and composition containing tandospirone |
| 02/21/2007 | CN1915191A Intrauterine device containing progesterone with no bracket |
| 02/21/2007 | CN1301285C Hydrous gel and production process and use of the hydrous gel |
| 02/21/2007 | CN1301263C Nucleotide sequence for anti HIV infection and preventing AIDS and use thereof |
| 02/21/2007 | CN1301262C Method for producing glucolipid substance using ganglioside as main component |
| 02/21/2007 | CN1301256C Method for preparing inophyllolide C2 and application of preparing medication of anti SARS |
| 02/21/2007 | CN1301255C Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 02/21/2007 | CN1301253C Pentatomic sulphur heterocyclic compound and its use for preparing medicine for treating preventing diseases related to adiposity |
| 02/21/2007 | CN1301249C Clausend wanpi acidamine C5 hydroxy derivative and N substituted derivative, its preparation method and its medicinal composition and use |
| 02/21/2007 | CN1301139C Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivs. |
| 02/21/2007 | CN1301134C Novel immune effect compound |
| 02/21/2007 | CN1301128C Coixenolide soft capsule for treating prostatic disease |
| 02/21/2007 | CN1301126C Coupling agent for external stone crushing and its preparing method |
| 02/21/2007 | CN1301112C Compound antimicrobial medicine containing N-acetophenetidin-D-chitosamine |
| 02/21/2007 | CN1301111C Use of phenoxthine compounds in preparing medicnies for promoting radio-sensitive medicines |
| 02/21/2007 | CN1301110C Antimicrobial atresia with tauryl amine derivatives and carboxyl acid and/or its salt |
| 02/21/2007 | CN1301109C Calcium, zinc and ferrum composite oral liquor and its preparing process |
| 02/21/2007 | CN1301108C Metaducine dispersion tablet and its preparation method |
| 02/21/2007 | CN1301107C Drop pills prepared from andrographolide sulfonated compounds and preparation method thereof |
| 02/21/2007 | CN1301106C Sterilizing gel |
| 02/21/2007 | CN1301105C Asthma treating spray |
| 02/21/2007 | CN1301094C Throat pain relieving anti-inflammation drop pills for treating oral disease and preparation method thereof |
| 02/20/2007 | US7179943 N-[3,5-bis(trifluoromethyl)phenyl]-1,8,8-trimethyl-2,4-dioxobicyclo[3.2.1]octane-3-carboxamide; treating convulsions, epilepsy, episodic ataxia, myokymia, neonatal convulsions, cerebral ischemia, cerebral palsy, stroke, traumatic brain injury, traumatic spinal cord injury |
| 02/20/2007 | US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes |
| 02/20/2007 | US7179939 Reacting ferric hydroxide, a sodium base and sodium gluconate, in an aqueous reaction mixture, isolating sodium ferric gluconate complex by adding to the aqueous reaction mixture a water-miscible organic solvent precipitating sodium ferric gluconate complex; free of excipients |
| 02/20/2007 | US7179926 Aryloxyalkylamine NK-1/SSRI inhibitors |
| 02/20/2007 | US7179924 Use of benzotriazole UV absorbers |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment |
| 02/20/2007 | US7179920 [4-(5-Chloro-2-hydroxy-phenyl)-2-oxo-6-trifluoromethyl- 1,2-dihydro-quinolin-3-ylsulfanyl]-acetic acid for example; potassium channel modulators for treating erectile dysfunction and irritable bowel syndrome |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179917 such as 3-(1-methylpyrrolidin-2-yl)-2-tricyclohexylstannanyl)pyridine derivative an intermediate for halonicotine or derivatives; acetylcholine receptor modulating activity |
| 02/20/2007 | US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 02/20/2007 | US7179896 Method of making PNA oligomers |
| 02/20/2007 | US7179849 Antimicrobial compositions containing colloids of oligodynamic metals |
| 02/20/2007 | US7179842 Method of treating non-insulin dependent diabetes mellitus with phytanic acid derivatives |
| 02/20/2007 | US7179841 Stabilized ascorbic acid compositions and methods therefor |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179838 Side effect reduction |
| 02/20/2007 | US7179837 Use of prenylated flavones |
| 02/20/2007 | US7179836 Using a thiophene compound; angiogenesis inhibitors; antiproliferative agents |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179834 Fermentation product of marine actinomyces strains ; antiproligferative agents; anticancer agents |
| 02/20/2007 | US7179833 Hydrogenation catalysts |
| 02/20/2007 | US7179832 Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof |
| 02/20/2007 | US7179831 Hydantoin derivatives; for treatment of asthma, chronic obstructive pulmonary diseases (COPD), arthritis, cancer, heart disease and nephritis |
| 02/20/2007 | US7179830 Such as 2-(4-methyl-3-thienylamino)-1H-thieno[3,4-d]imidazole for treatment of repiratory disorders, sleep apnea |
| 02/20/2007 | US7179829 Such as trans-(2-chloro-6-trifluoromethylphenyl)-(octahydrobenzimidazol-2-ylidene)amine hydrochloride; for treatment/prophylaxis of central nervous system disorders, lipid metabolism, infection by ectoparasites, disorders of gall function, improving respiratory drive/snoring |
| 02/20/2007 | US7179828 Antiproliferative, anticarcinogenic and antifungal agents; food and cosmetic preservatives |
| 02/20/2007 | US7179827 Such as (S)-(4-(ethylamino)-2-((4-methylpiperidin-1-yl)methyl)thiazol-5-yl)(2-(methoxymethyl)pyrrolidin-1-yl)methanone; for treatment of neurological and psychiatric disorders/diseases, cancer, and disorders mediated by protein kinase inhibition |
| 02/20/2007 | US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179820 Administering to an animal having ocular hypertension a piperidynly analog as for example 7-[2-oxo-6-((E)-3-oxo-oct-1-enyl)-piperidin-1-yl]-hept-5-ynoic acid methyl ester |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/20/2007 | US7179818 Substituted aminoquinuclidine compounds |
| 02/20/2007 | US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid |
| 02/20/2007 | US7179816 Chemical derivatives and their application as antitelomerase agents |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179813 Bicyclic indolyl derivatives and methods for their use as serotonergic agents |
| 02/20/2007 | US7179812 Such as 3-(4-[1,2,3]Triazol-1-yl-but-1-ynyl)-6-{2-[2-(4-trifluoromethyl-phenyl)-vinyl]-oxazol-4-ylmethoxy}-pyridazine; for treatment of cancer, tumor growth; antiproliferative agents |
| 02/20/2007 | US7179811 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections |
| 02/20/2007 | US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 02/20/2007 | US7179809 2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions |
| 02/20/2007 | US7179808 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors |